Evidence map›Paper›PMID 39425141›Full record

ReviewOrphanet journal of rare diseases2024

Quality of life and unmet needs in patients with fabry disease: a qualitative study.

Montserrat Morales, Jordi Cruz, Eduardo Brignani, Laura Acuña, Esther Lázaro, Cristina Soria

Registry-linked trialAbstract readReview
In one paragraph

Review in Orphanet journal of rare diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07560956 (Quality of Life in Patients With Untreated Fabry Disease), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07560956 enrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Quality of Life in Patients With Untreated Fabry Disease: A National Descriptive Study

TypeobservationalSponsorVastra Gotaland RegionRan2026 to 2027Enrolled35ConditionsFabry DiseaseArmsQualitative Interview
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Fabry Disease: A Focus on the Role of Oxidative Stress.Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Montserrat MoralesHospital Universitario 12 de Octubre, Unidad de Adultos de Enfermedades Raras y Errores Congénitos Del Metabolismo, Madrid, España.
Jordi CruzAsociación MPS-LISOSOMALES, Igualada, España.
Eduardo BrignaniAsociación MPS-LISOSOMALES, Igualada, España.
Laura AcuñaDepartamento Médico, Chiesi, España.
Esther LázaroFacultad de Ciencias de la Salud, Universidad Internacional de Valencia, Valencia, España. estherlazaroperez2020@gmail.com.ORCID 0000-0001-9334-8687
Cristina SoriaPsicología de la Salud, Suportias, Madrid, España.

Funding

Chiesi España Chiesi España
6 · The paper itself

Abstract

backgroundPatients with Fabry disease (FD) consider their quality of life to be significantly affected. The majority of studies evaluate the quality of life using quantitative measures and standardised scales that offer relevant information about experience with the disease in multiple aspects. The main objective of the research was to examine in depth the quality of life and unmet needs of patients diagnosed with FD in relation to their disease and treatment. A qualitative and transversal study was carried out in two stages: (a) nine semi-structured qualitative interviews with patients and one representative of the patient association, conducted individually by phone; (b) a focus group was set up with three patients diagnosed with FD and one relative. A deductive, thematic analysis approach was used for data coding and analysis.

resultsThe analysis of the interviews revealed various relevant themes: experience with the disease, impact on daily activities, experience of the family and work environment, experience related to treatment and healthcare professionals, and unmet support needs. Diagnosis has a significant impact on both those suffering from the disease and on the family environment. The symptoms and evolution of the disease are highly variable among the patients interviewed and depend on the years diagnosed as well as the time taken to receive the diagnosis. The families of the interviewees have to go through an adjustment process in light of the significant psychological impact brought about by the disease. Patients show various unmet needs. The need mentioned most is to have more information, support, and understanding from people around them and society, improving empathy and raising awareness about the difficulties faced by people with FD while giving the disease visibility. A lack of social understanding is highlighted as one of the main challenges, as this does not only affect the emotional management of the disease but also has repercussions on working life and social relationships.

conclusionsIt seems necessary to define possible strategies that help to improve the quality of life of patients and their experience with the disease. Some recommendations obtained from the study include: facilitate access to mental health professionals for patients and their families; improve training for specialists and coordination among them; and carry out actions to raise awareness of the disease that are aimed at the general public, the patients themselves, and the people around them.

Indexed as

Fabry DiseaseQuality of LifeAdultFemaleHumansMaleMiddle AgedQualitative ResearchFabry diseaseQualitative studyQuality of lifeUnmet needs

Identifiers

PMID39425141
PMCPMC11490088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.